This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Tactical

  • Research type

    Research Study

  • Full title

    A Phase I/II randomised study of Tarceva (Elotonib), used concurrently with thoracic radiation in patients with advanced non-small cell lung cancer.

  • IRAS ID

    2658

  • Contact name

    Stephen Mangar

  • Contact email

    s.mangar@imperial.ac.uk

  • Sponsor organisation

    Imperial College NHS Healthcare Trust

  • Eudract number

    2008-001431-35

  • ISRCTN Number

    N/A

  • REC name

    West Midlands - Edgbaston Research Ethics Committee

  • REC reference

    08/H1208/41

  • Date of REC Opinion

    14 Oct 2008

  • REC opinion

    Further Information Favourable Opinion